Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)
China · Delayed Price · Currency is CNY 2.330
+0.030 (1.30%)
Jul 31, 2026, 3:00 PM CST
SHA:600165 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,765 | 6,706 | 1,664 | 2,315 | 4,630 | 9,198 | |
Market Cap Growth | 29.35% | 302.94% | -28.11% | -50.00% | -49.66% | 83.22% |
Enterprise Value | 4,482 | 7,674 | 2,970 | 4,280 | 6,463 | 10,967 |
Last Close Price | 2.33 | 4.15 | 2.43 | 3.38 | 6.76 | 13.43 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 33.67 | 33.67 | 33.67 | 37.56 | - |
PS Ratio | 8.04 | 15.09 | 4.82 | 8.10 | 6.80 | 36.98 |
PB Ratio | 2.96 | 5.02 | 6.93 | 7.57 | 5.18 | 8.65 |
P/TBV Ratio | 3.47 | 5.84 | 357.62 | 93.19 | 8.42 | 12.81 |
P/OCF Ratio | - | - | - | 99.98 | 87.12 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 9.57 | 17.27 | 8.60 | 14.98 | 9.49 | 44.09 |
EV/EBITDA Ratio | - | - | - | - | 184.25 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.68 | 0.64 | 2.82 | 5.57 | 1.81 | 1.41 |
Debt / EBITDA Ratio | - | - | - | - | 45.58 | - |
Net Debt / Equity Ratio | 0.46 | 0.30 | 2.78 | 5.49 | 1.71 | 1.31 |
Net Debt / EBITDA Ratio | -3.72 | -2.04 | -8.23 | -25.95 | 43.49 | -9.87 |
Net Debt / FCF Ratio | -0.79 | -0.61 | -7.32 | -48.63 | -247.43 | -5.38 |
Asset Turnover | 0.21 | 0.19 | 0.14 | 0.09 | 0.21 | 0.08 |
Inventory Turnover | 4.54 | 5.89 | 4.84 | 4.09 | 4.99 | 3.45 |
Quick Ratio | 1.82 | 2.13 | 0.04 | 0.05 | 0.08 | 0.12 |
Current Ratio | 2.71 | 2.77 | 0.11 | 0.11 | 0.16 | 0.29 |
Return on Equity (ROE) | -21.38% | -20.67% | -211.44% | -85.90% | -17.38% | -16.21% |
Return on Assets (ROA) | -7.82% | -8.64% | -5.08% | -4.05% | -1.66% | -3.77% |
Return on Invested Capital (ROIC) | -15.91% | -24.38% | -14.40% | -9.18% | -3.59% | -8.23% |
Return on Capital Employed (ROCE) | -13.30% | -14.60% | -77.30% | -18.80% | -5.10% | -9.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.41% | -1.35% | -32.38% | -20.08% | -3.06% | -1.81% |
FCF Yield | -19.75% | -9.61% | -5.49% | -1.49% | -0.13% | -2.81% |
Buyback Yield / Dilution | -169.93% | -135.68% | -0.05% | -0.13% | -0.00% | -1.35% |